| Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia R Romee, M Rosario, MM Berrien-Elliott, JA Wagner, BA Jewell, ... Science translational medicine 8 (357), 357ra123-357ra123, 2016 | 787 | 2016 |
| First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation R Romee, S Cooley, MM Berrien-Elliott, P Westervelt, MR Verneris, ... Blood, The Journal of the American Society of Hematology 131 (23), 2515-2527, 2018 | 355 | 2018 |
| CD56bright NK cells exhibit potent antitumor responses following IL-15 priming JA Wagner, M Rosario, R Romee, MM Berrien-Elliott, SE Schneider, ... The Journal of clinical investigation 127 (11), 4042-4058, 2017 | 323 | 2017 |
| Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma K Krysiak, F Gomez, BS White, M Matlock, CA Miller, L Trani, CC Fronick, ... Blood, The Journal of the American Society of Hematology 129 (4), 473-483, 2017 | 193 | 2017 |
| CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas M Gang, ND Marin, P Wong, CC Neal, L Marsala, M Foster, T Schappe, ... Blood, The Journal of the American Society of Hematology 136 (20), 2308-2318, 2020 | 162 | 2020 |
| Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia MM Berrien-Elliott, AF Cashen, CC Cubitt, CC Neal, P Wong, JA Wagner, ... Cancer discovery 10 (12), 1854-1871, 2020 | 107 | 2020 |
| Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated blood and cord blood–derived NK cells facilitates CAR-like responses against CD30+ malignancies LN Kerbauy, ND Marin, M Kaplan, PP Banerjee, MM Berrien-Elliott, ... Clinical Cancer Research 27 (13), 3744-3756, 2021 | 101 | 2021 |
| Human cytokine-induced memory-like natural killer cells MM Berrien-Elliott, JA Wagner, TA Fehniger Journal of innate immunity 7 (6), 563-571, 2015 | 95 | 2015 |
| Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis C Cantoni, F Cignarella, L Ghezzi, B Mikesell, B Bollman, ... Acta neuropathologica 133, 61-77, 2017 | 87 | 2017 |
| Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant JJ Bednarski, C Zimmerman, MM Berrien-Elliott, JA Foltz, ... Blood, The Journal of the American Society of Hematology 139 (11), 1670-1683, 2022 | 81 | 2022 |
| Allogeneic natural killer cell therapy MM Berrien-Elliott, MT Jacobs, TA Fehniger Blood 141 (8), 856-868, 2023 | 73 | 2023 |
| Memory-like natural killer cells for cancer immunotherapy M Gang, P Wong, MM Berrien-Elliott, TA Fehniger Seminars in hematology 57 (4), 185-193, 2020 | 70 | 2020 |
| Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis MR Mack, JR Brestoff, MM Berrien-Elliott, AM Trier, TLB Yang, ... Science translational medicine 12 (532), eaay1005, 2020 | 68 | 2020 |
| Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy MM Berrien-Elliott, M Becker-Hapak, AF Cashen, M Jacobs, P Wong, ... Blood, The Journal of the American Society of Hematology 139 (8), 1177-1183, 2022 | 67 | 2022 |
| Cytokine-induced memory-like differentiation enhances unlicensed natural killer cell antileukemia and FcγRIIIa-triggered responses JA Wagner, MM Berrien-Elliott, M Rosario, JW Leong, BA Jewell, ... Biology of Blood and Marrow Transplantation 23 (3), 398-404, 2017 | 66 | 2017 |
| Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia MM Berrien-Elliott, JA Foltz, DA Russler-Germain, CC Neal, J Tran, ... Science translational medicine 14 (633), eabm1375, 2022 | 65 | 2022 |
| Potently cytotoxic natural killer cells initially emerge from erythro-myeloid progenitors during mammalian development C Dege, KH Fegan, JP Creamer, MM Berrien-Elliott, SA Luff, D Kim, ... Developmental cell 53 (2), 229-239. e7, 2020 | 64 | 2020 |
| MicroRNA-15/16 antagonizes Myb to control NK cell maturation RP Sullivan, JW Leong, SE Schneider, AR Ireland, MM Berrien-Elliott, ... The Journal of Immunology 195 (6), 2806-2817, 2015 | 58 | 2015 |
| Improving natural killer cell cancer immunotherapy MM Berrien-Elliott, R Romee, TA Fehniger Current opinion in organ transplantation 20 (6), 671-680, 2015 | 57 | 2015 |
| Durable Adoptive Immunotherapy for Leukemia Produced by Manipulation of Multiple Regulatory Pathways of CD8+ T-Cell Tolerance MM Berrien-Elliott, SR Jackson, JM Meyer, CJ Rouskey, TLM Nguyen, ... Cancer research 73 (2), 605-616, 2013 | 55 | 2013 |
Todd A Fehniger MD/PhDProfessor of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis在 wustl.edu 的电子邮件经过验证
